Handheld Device Uses Light Energy in Treatments
By HospiMedica International staff writers Posted on 24 Jun 2018 |
Image: The Celluma pod-shaped device emitting healing light therapy (Photo courtesy of BioPhotas).
A novel device delivers blue, red, and near-infrared (NIR) light energy to safely address a wide variety of musculoskeletal and dermatological conditions.
The BioPhotas (Anaheim, CA, USA) Celluma POD light therapy device emits light in a range of wavelengths, which are absorbed by molecules participating in diverse cellular processes. The result is decreased inflammation, increased microcirculation, and an increase in collagen production, all speeding cellular healing. The Celluma POD is designed to treat periorbital and full-face wrinkles, acne, muscle and joint pain, muscle and joint stiffness, muscle tissue tension, muscle spasm, arthritis, and compromised local blood circulation.
The photonic energy is delivered via light emitting diode (LED) technology, which stimulates the basic energy process in the mitochondria of each cell, particularly under NIR light. In addition, according to the U.S. National Aeronautics and Space Administration (NASA), DNA synthesis in fibroblasts and muscle cells is quadrupled when exposed to LED light. The pod-shaped handheld device can be applied almost anywhere on the body, or even used in a hands-free form in certain treatments areas.
“Leveraging the clinically-proven performance of our LED panel devices, we are introducing a handheld LED device that is different from any other device available on the market today,” said Patrick Johnson, President and CEO of BioPhotas. “Typically, handheld light therapy devices are configured for a single purpose, like treating pain or acne. However, the Celluma POD has three separate programs all in a single device for treating acne, wrinkles, and musculoskeletal pain in a targeted fashion.”
Light therapy consists of exposure to daylight or to specific wavelengths of using polychromatic polarized light, lasers, LEDs, fluorescent lamps, dichroic lamps or very bright, full-spectrum light. The light is administered for a prescribed amount of time and, in some cases, at a specific time of day.
Related Links:
BioPhotas
The BioPhotas (Anaheim, CA, USA) Celluma POD light therapy device emits light in a range of wavelengths, which are absorbed by molecules participating in diverse cellular processes. The result is decreased inflammation, increased microcirculation, and an increase in collagen production, all speeding cellular healing. The Celluma POD is designed to treat periorbital and full-face wrinkles, acne, muscle and joint pain, muscle and joint stiffness, muscle tissue tension, muscle spasm, arthritis, and compromised local blood circulation.
The photonic energy is delivered via light emitting diode (LED) technology, which stimulates the basic energy process in the mitochondria of each cell, particularly under NIR light. In addition, according to the U.S. National Aeronautics and Space Administration (NASA), DNA synthesis in fibroblasts and muscle cells is quadrupled when exposed to LED light. The pod-shaped handheld device can be applied almost anywhere on the body, or even used in a hands-free form in certain treatments areas.
“Leveraging the clinically-proven performance of our LED panel devices, we are introducing a handheld LED device that is different from any other device available on the market today,” said Patrick Johnson, President and CEO of BioPhotas. “Typically, handheld light therapy devices are configured for a single purpose, like treating pain or acne. However, the Celluma POD has three separate programs all in a single device for treating acne, wrinkles, and musculoskeletal pain in a targeted fashion.”
Light therapy consists of exposure to daylight or to specific wavelengths of using polychromatic polarized light, lasers, LEDs, fluorescent lamps, dichroic lamps or very bright, full-spectrum light. The light is administered for a prescribed amount of time and, in some cases, at a specific time of day.
Related Links:
BioPhotas
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration